Professor Yogesan Kanagasingam is highly recognised for his work in developing innovative technology for treating eye disease, and has received numerous honours and awards. He achieved a Fulbright Scholarship to Stanford University School of Medicine in 2011, where he worked on developing a non-invasive imaging device to screen premature babies for retinal abnormalities.
Dr Kanagasingam has developed e-Health and medical technologies from bench to bed and one of his inventions is used by NASA in the International Space Station. He invented a remote digital retinopathy device, which is being widely deployed to help identify diabetes and other early stage diseases.
Dr Kanagasingam has published more than 150 peer-reviewed papers and four books in telemedicine and digital homecare. He also has a patent portfolio of more than 35 patent applications.
He was the national research director of the Australian Telehealth Research and Development Centre and worked at The University of Western Australia.
Dr Kanagasingam is a Visiting Scholar to Harvard University and Professor at the School of Medicine at the University of Notre Dame. In July 2021, Dr Kanagasingam was appointed the inaugural chair of Digital Health and Telemedicine at the University of Notre Dame Australia and will focus on building contemporary and cutting-edge practices in digital health and telehealth plans for St John of God Midland Public and Private Hospitals.